Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Cymbio Pharma Private Limited, is an unlisted private company incorporated on 14 September, 1998. It is classified as a private limited company and is located in Bangalore, Karnataka. It's authorized share capital is INR 10.00 cr and the total paid-up capital is INR 2.50 cr.
Cymbio Pharma's operating revenue range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2023. It's EBITDA has decreased by 57.74% over the previous year. At the same time, it's book networth has increased by 4.43%.
Read more
** All rupee values in INR crores. Based on March 2023 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Sudarshan Karle
Shareholder
|
00291428 | 22 years |
| Director | Mahendra Karle
Shareholder
|
00291472 | 22 years |
| Director | Fiona Karle | 00291559 | 21 years |
| Director | Kyung Seon Cho | 02687809 | 21 years |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Union Bank of India
No. of Loans: 2
Total Amount : 10.3 cr
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| LAKESHORE DEVELOPMENTS PRIVATE LIMITED |
Strike Off
|
1.0 L | 2 | Karnataka |
| KARLE HOMES PRIVATE LIMITED |
Active
|
31.4 Cr | 2 | Goa |
| BRAIN 'N' BEYOND BIOTECH PRIVATE LIMITED |
Active
|
1.0 Cr | 2 | Karnataka |
| KARLE SINGLUN INTERNATIONAL PRIVATE LIMI TED |
Strike Off
|
1.0 L | 2 | Karnataka |
| KARLE HEALTH SCIENCES PRIVATE LIMITED |
Active
|
1.0 L | 2 | Karnataka |
| KARLE PACKAGING PRIVATE LIMITED |
Active
|
1.0 L | 2 | Karnataka |
| ETI KARLE CLINICAL PRIVATE LIMITED |
Active
|
1.0 L | 2 | Karnataka |
| KARLE TECH PARK PRIVATE LIMITED |
Active
|
1.0 L | 2 | Karnataka |
| KARLE BUSINESS PARK PRIVATE LIMITED |
Active
|
1.0 L | 2 | Karnataka |
| KARLE INTERNATIONAL PRIVATE LIMITED |
Active
|
63.1 Cr | 2 | Karnataka |
| KARLE INFRA PRIVATE LIMITED |
Active
|
57.6 Cr | 1 | Karnataka |
Read more
The incorporation date of CYMBIO PHARMA PRIVATE LIMITED is 14 September, 1998
The authorized share capital of CYMBIO PHARMA PRIVATE LIMITED is INR ₹ 10.0 Cr.
The paid-up capital of CYMBIO PHARMA PRIVATE LIMITED is INR ₹ 2.5 Cr.
The registered address of CYMBIO PHARMA PRIVATE LIMITED is No.23/4, Venkatala Yelahanka Hobli Yelahanka BANGALORE Karnataka - 560064
The CIN number of CYMBIO PHARMA PRIVATE LIMITED is U85110KA1998PTC024210.